Genmab A/S (GMAB) Stock Price & News

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia

About Genmab A/S

CEOJan G. J. van de Winkel

Employees3.12K

Founded1999

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitegenmab.com

All values in DKK	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Revenue	4.68B	4.14B	5.40B	5.54B
Cost of goods sold	-	-	-	273.00M
Cost of revenue	-	-	-	273.00M
Research and development expenses	-	-	-	2.28B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	865.00M
Operating expense	-	-	-	3.15B
Total operating expenses	-	-	-	3.42B
Operating income	-	-	-	2.12B
Other non operating income	-	-	-	-
EBT including unusual items	-	-	-	1.72B
EBT excluding unusual items	-	-	-	1.59B
Income tax expense	-	-	-	453.00M
Effective tax rate	-	-	-	26.35%
Other operating expenses	-	-	-	-
Net income	-	-	-	1.27B
Net profit margin	-	-	-	22.85%
Earnings per share	9.67	-	-	19.81
Interest and investment income	-	-	-	162.00M
Interest expense	-	-	-	-18.00M
Net interest expenses	-	-	-	144.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	2.20B
Gain or loss from assets sale	-	-	-	-

Ask anything